Acarix AS (Sweden) Today
| ACARIX Stock | SEK 0.30 0.01 3.23% |
Performance0 of 100
| Odds Of DistressOver 68
|
Acarix AS is trading at 0.3 as of the 29th of November 2024, a 3.23 percent down since the beginning of the trading day. The stock's open price was 0.31. Acarix AS has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Acarix AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of May 2023 and ending today, the 29th of November 2024. Click here to learn more.
Acarix AB , a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States. Acarix AB was founded in 2004 and is based in Malm, Sweden. Acarix AB operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. The company has 373.33 M outstanding shares. More on Acarix AS
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Acarix Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Acarix AS's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Acarix AS or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Acarix AS (ACARIX) is traded on Stockholm Exchange in Sweden and employs 8 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 107.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Acarix AS's market, we take the total number of its shares issued and multiply it by Acarix AS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Acarix AS operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 373.33 M outstanding shares.
Acarix AS has accumulated about 15.86 M in cash with (48.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Acarix AS Probability Of Bankruptcy
Ownership AllocationAcarix AS holds a total of 373.33 Million outstanding shares. Acarix AS shows 10.28 percent of its outstanding shares held by insiders and 2.84 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Acarix Ownership Details
Acarix AS Risk Profiles
Although Acarix AS's alpha and beta are two of the key measurements used to evaluate Acarix AS's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.75 | |||
| Semi Deviation | 3.98 | |||
| Standard Deviation | 6.21 | |||
| Variance | 38.59 |
Acarix Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Acarix AS without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Acarix AS Corporate Management
Elected by the shareholders, the Acarix AS's board of directors comprises two types of representatives: Acarix AS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acarix. The board's role is to monitor Acarix AS's management team and ensure that shareholders' interests are well served. Acarix AS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acarix AS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christian Lindholm | Chief Officer | Profile | |
| Marianne Norskov | Chief Officer | Profile | |
| Helen Round | Pres CEO | Profile | |
| Thomas Lundstrm | Chief Officer | Profile | |
| Tobias Fritz | Chief Officer | Profile | |
| Anders Krabbe | Chief Officer | Profile |
Other Information on Investing in Acarix Stock
Acarix AS financial ratios help investors to determine whether Acarix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Acarix with respect to the benefits of owning Acarix AS security.